Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Grasso

Showing results (201-210 of 226) with videos related to

Pageof 23
Sort By:
European Journal of Pharmacology|April 5, 2000
In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhageM Buemi, G Grasso, F Corica, et al.
European Neurology|January 11, 2001
Patterns of cognitive impairment in secondary progressive stable phase of multiple sclerosis: correlations with MRI findingsU Nocentini, P M Rossini, G A Carlesimo, et al.
Journal of Environmental Management|October 28, 2025
Increasing occurrence of the bearded fireworm (Hermodice carunculata) poses a threat for small-scale fisheries in the central Mediterranean SeaF Rescio, C Scianna, A Di Franco, et al.
Italian Journal of Neurological Sciences|August 10, 2000
Post-stroke rehabilitation: an economic or medical priority? Current issues and prospects in light of new legislative regulationsS Paolucci, M Traballesi, L Emberti Gialloreti, et al.
Cell Death & Disease|June 13, 2015
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patientsM T Cencioni, S Santini, G Ruocco, et al.
Pharmacology & Therapeutics|May 23, 2020
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edgesG R Tundo, D Sbardella, A M Santoro, et al.
Cell Death & Disease|May 8, 2015
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patientsM T Cencioni, S Santini, G Ruocco, et al.
Pathologica|June 1, 1996
[Audit of histopathology activities at the pathology departments of 7 general hospitals. 2. Response time]A Andrion, A Gaglio, A Langè, et al.
Pathologica|February 1, 1996
[Audit of histopathological activities in the laboratories of 7 general hospitals. 1. Types of resources and quantitative aspects of the workload]A Andrion, E Feyles, A Langè, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 30, 2016
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventoriesA M Giovannetti, E Pietrolongo, A Giordano, et al.
Pageof 23

Showing results (201-210 of 226) with videos related to

Sort By:
Pageof 23
European Journal of Pharmacology|April 5, 2000
In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhageM Buemi, G Grasso, F Corica, et al.
European Neurology|January 11, 2001
Patterns of cognitive impairment in secondary progressive stable phase of multiple sclerosis: correlations with MRI findingsU Nocentini, P M Rossini, G A Carlesimo, et al.
Journal of Environmental Management|October 28, 2025
Increasing occurrence of the bearded fireworm (Hermodice carunculata) poses a threat for small-scale fisheries in the central Mediterranean SeaF Rescio, C Scianna, A Di Franco, et al.
Italian Journal of Neurological Sciences|August 10, 2000
Post-stroke rehabilitation: an economic or medical priority? Current issues and prospects in light of new legislative regulationsS Paolucci, M Traballesi, L Emberti Gialloreti, et al.
Cell Death & Disease|June 13, 2015
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patientsM T Cencioni, S Santini, G Ruocco, et al.
Pharmacology & Therapeutics|May 23, 2020
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edgesG R Tundo, D Sbardella, A M Santoro, et al.
Cell Death & Disease|May 8, 2015
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patientsM T Cencioni, S Santini, G Ruocco, et al.
Pathologica|June 1, 1996
[Audit of histopathology activities at the pathology departments of 7 general hospitals. 2. Response time]A Andrion, A Gaglio, A Langè, et al.
Pathologica|February 1, 1996
[Audit of histopathological activities in the laboratories of 7 general hospitals. 1. Types of resources and quantitative aspects of the workload]A Andrion, E Feyles, A Langè, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 30, 2016
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventoriesA M Giovannetti, E Pietrolongo, A Giordano, et al.
Pageof 23